Non-responders to Antiplatelet Treatment in Acute Ischaemic Stroke)
NCT02607358 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 496
Last updated 2016-10-13
Summary
Determination of frequency of Clopidigrel- and Acetacylicacid-non-responders (HOTPR) in acute ischemic stroke patients.
Conditions
- Acute Ischemic Stroke
Interventions
- OTHER
-
blood sampling for HOTPR-testing
All subjects are tested for responderstatus using the VerifyNow System
Sponsors & Collaborators
-
Zealand University Hospital
lead OTHER
Principal Investigators
-
Charlotte Rath, MD · Zealand University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2016-08-31
- Completion
- 2016-08-31
Countries
- Denmark
Study Locations
More Related Trials
-
Novel Oral Anticoagulants in Stroke Patients
NCT02353585 ·Status: COMPLETED
-
Study of Tenecteplase Versus Alteplase for Thrombolysis (Clot Dissolving) in Acute Ischemic Stroke
NCT01949948 ·Status: COMPLETED ·Phase: PHASE3
-
To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection
NCT00238667 ·Status: COMPLETED ·Phase: PHASE3
-
Stroke Treatment With Acute Reperfusion and Simvastatin
NCT01073007 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke
NCT00840671 ·Status: COMPLETED ·Phase: PHASE3
-
Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke
NCT02388061 ·Status: COMPLETED ·Phase: PHASE2
-
Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack
NCT00931788 ·Status: COMPLETED ·Phase: PHASE4
-
New Oral Anticoagulants (NOAC) in Stroke Patients
NCT03826927 ·Status: COMPLETED
-
Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack
NCT00363753 ·Status: WITHDRAWN ·Phase: PHASE1
-
Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease
NCT02953405 ·Status: UNKNOWN
-
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)
NCT01472926 ·Status: COMPLETED ·Phase: PHASE2
-
TIMING of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation
NCT02961348 ·Status: COMPLETED ·Phase: NA
-
The Norwegian Tenecteplase Stroke Trial 2
NCT03854500 ·Status: TERMINATED ·Phase: PHASE3
-
A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion
NCT02398656 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke
NCT00860366 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pre-stroke Cognitive Status and Thrombolytic Therapy
NCT01713491 ·Status: COMPLETED
-
Dabigatran Following Transient Ischemic Attack and Minor Stroke
NCT02295826 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator
NCT01006993 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-Dependent Effect of Early Antiplatelet Therapy in Acute Ischemic Stroke
NCT01273935 ·Status: COMPLETED
-
Biomarkers of Acute Stroke in Clinic
NCT03897478 ·Status: UNKNOWN
-
Thrombolysis Outcome in Ischemic Stroke
NCT04309357 ·Status: COMPLETED
-
Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis
NCT06058130 ·Status: RECRUITING ·Phase: NA
-
Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
NCT06781385 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Antiplatelet Therapy for AIS Patients With Thrombocytopenia
NCT06053021 ·Status: RECRUITING ·Phase: NA
-
Impact of Neutrophil Extracellular Traps on Tissue Plasminogen Activator Induced Thrombolysis in Acute Ischemic Stroke Patients
NCT02907736 ·Status: WITHDRAWN